Second Ebola vaccine set to be used soon in Democratic Republic of the Congo
The Democratic Republic of the Congo will begin using a second Ebola vaccine as early as next week, the company developing the experimental product, Johnson & Johnson, said Thursday. J&J announced it is donating enough of the product to vaccinate up to 500,000 people.
The vaccine will be used as part of a clinical trial, but the aim is as much to help extinguish the long-running outbreak in the country’s northeast as it is to gather data on the effectiveness of the vaccine, which does not yet have a brand name.
